These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 15894658)

  • 1. Association of breast cancer risk with a common functional polymorphism (Asp327Asn) in the sex hormone-binding globulin gene.
    Cui Y; Shu XO; Cai Q; Jin F; Cheng JR; Cai H; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1096-101. PubMed ID: 15894658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of endometrial cancer risk with a functional polymorphism (Asp(327)Asn) in the sex hormone-binding globulin gene.
    Kataoka N; Cai Q; Xu WH; Xiang YB; Cai H; Zheng W; Shu XO
    Cancer; 2007 Apr; 109(7):1296-302. PubMed ID: 17315164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
    Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of cyclin D1 genotype with breast cancer risk and survival.
    Shu XO; Moore DB; Cai Q; Cheng J; Wen W; Pierce L; Cai H; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):91-7. PubMed ID: 15668481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics.
    Dai Q; Franke AA; Yu H; Shu XO; Jin F; Hebert JR; Custer LJ; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):497-502. PubMed ID: 12814993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women.
    Ren Z; Cai Q; Shu XO; Cai H; Li C; Yu H; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1290-5. PubMed ID: 15298948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Val158Met Polymorphism in catechol-O-methyltransferase gene associated with risk factors for breast cancer.
    Hong CC; Thompson HJ; Jiang C; Hammond GL; Tritchler D; Yaffe M; Boyd NF
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):838-47. PubMed ID: 14504192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based case-control study of CYP11A gene polymorphism and breast cancer risk.
    Zheng W; Gao YT; Shu XO; Wen W; Cai Q; Dai Q; Smith JR
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):709-14. PubMed ID: 15159300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CYP19 gene codon 39 Trp/Arg polymorphism increases breast cancer risk in subsets of premenopausal Japanese.
    Hirose K; Matsuo K; Toyama T; Iwata H; Hamajima N; Tajima K
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1407-11. PubMed ID: 15298966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptive use and breast cancer risk: modification by NAD(P)H:quinone oxoreductase (NQO1) genetic polymorphisms.
    Fowke JH; Shu XO; Dai Q; Jin F; Cai Q; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1308-15. PubMed ID: 15298951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
    Quick SK; Shields PG; Nie J; Platek ME; McCann SE; Hutson AD; Trevisan M; Vito D; Modali R; Lehman TA; Seddon M; Edge SB; Marian C; Muti P; Freudenheim JL
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1082-7. PubMed ID: 18483329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cytochrome P4502E1 genetic polymorphism and tobacco smoking in breast cancer.
    Shields PG; Ambrosone CB; Graham S; Bowman ED; Harrington AM; Gillenwater KA; Marshall JR; Vena JE; Laughlin R; Nemoto T; Freudenheim JL
    Mol Carcinog; 1996 Nov; 17(3):144-50. PubMed ID: 8944074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
    J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms in the estrogen receptor alpha gene and risk of breast cancer: results from the Shanghai Breast Cancer Study.
    Cai Q; Shu XO; Jin F; Dai Q; Wen W; Cheng JR; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):853-9. PubMed ID: 14504194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in CYP1A1 and breast carcinoma risk in a population-based case-control study of Chinese women.
    Boyapati SM; Shu XO; Gao YT; Cai Q; Jin F; Zheng W
    Cancer; 2005 Jun; 103(11):2228-35. PubMed ID: 15856430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Breast Cancer Res Treat; 2010 Jan; 119(2):463-74. PubMed ID: 19424794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.